mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.06 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.06 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |